Cantor Fitzgerald Starts Cara Therapeutics (CARA) at Buy
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Cara Therapeutics (NASDAQ: CARA) with a Buy rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Cara Therapeutics click here. For more ratings news on Cara Therapeutics click here.
Shares of Cara Therapeutics closed at $15.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- Raymond James Resumes Ally Financial (ALLY) at Strong Buy
- Morgan Stanley Resumes Vertex (VRTX) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
